TriSalus Life Sciences, Inc. ( TLSI) - Key Metrics
TLSI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.28 | -$0.21 | -$0.05 | -$0.05 |
| 2025Q3 | $0.27 | -$0.25 | -$0.09 | -$0.09 |
| 2025Q2 | $0.34 | -$0.25 | -$0.22 | -$0.22 |
| 2025Q1 | $0.32 | -$0.36 | -$0.16 | -$0.18 |
TLSI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -8.38 |
| 2025Q3 | ? | -4.63 |
| 2025Q2 | ? | -5.41 |
| 2025Q1 | ? | -3.79 |
TLSI
Price: $4.16
52 week price:
Earnings Per Share: -1.42 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 126.4 million